Arylacetamide Deacetylase-Like 2 (AADACL2) Antibody (FITC)

Background

Arylacetamide deacetylase like 2 (AADACL2) is a member of the serine hydrolase family and is primarily involved in lipid metabolism and the hydrolysis of specific substrates, including arylacetamides and other ester-containing lipids. While its precise physiological roles are still under investigation, AADACL2 is thought to contribute to the breakdown and remodeling of lipid molecules, particularly in metabolic tissues such as the liver and adipose tissue. It has been implicated in pathways regulating energy balance and lipid signaling, suggesting potential roles in maintaining metabolic homeostasis. Dysregulation of AADACL2 expression or activity may contribute to metabolic disorders, although its exact contribution to disease pathology remains unclear. The enzyme's function in lipid metabolism highlights its importance in understanding broader lipid-regulatory networks and its potential as a target for therapeutic intervention in metabolic diseases.